Applied Therapeutics Stock In The News
| APLT Stock | USD 9.63 0.36 3.88% |
Our overall analysis of Applied Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Applied Therapeutics. The specific impact of Applied Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Applied Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Applied Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Applied Therapeutics Backtesting and Applied Therapeutics Hype Analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.
Applied |
Applied Therapeutics Today Top News and Investor Outlook
Applied Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Applied and other traded companies coverage with news coverage. We help investors stay connected with Applied headlines for the 24th of November to make an informed investment decision based on correlating the impacts of news items on Applied Stock performance. Please note that trading solely based on the Applied Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Applied Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Applied earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Applied Therapeutics that are available to investors today. That information is available publicly through Applied media outlets and privately through word of mouth or via Applied internal channels. However, regardless of the origin, that massive amount of Applied data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Applied Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Applied Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Applied Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Applied Therapeutics alpha.
Applied Largest EPS Surprises
Earnings surprises can significantly impact Applied Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-09 | 2022-09-30 | -0.48 | -0.4 | 0.08 | 16 | ||
2024-03-06 | 2023-12-31 | -0.23 | -0.34 | -0.11 | 47 | ||
2023-08-10 | 2023-06-30 | -0.26 | -0.37 | -0.11 | 42 | ||
2019-08-12 | 2019-06-30 | -0.49 | -0.6 | -0.11 | 22 | ||
2023-05-11 | 2023-03-31 | -0.31 | -0.18 | 0.13 | 41 | ||
2021-08-12 | 2021-06-30 | -1.13 | -0.99 | 0.14 | 12 |
Applied Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Applied Therapeutics Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
15th of November 2024
Perceptive Advisors LLC Expands Stake in Applied Therapeutics Inc at gurufocus.com
7th of November 2024
Morgan Stanleys Strategic Acquisition of Applied Therapeutics Inc Shares at gurufocus.com
29th of October 2024
Applied Therapeutics Upgraded to Buy Heres What You Should Know at zacks.com
16th of October 2024
Applied Therapeutics Trading Down 2.2 percent Heres What Happened at thelincolnianonline.com
30th of September 2024
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference at finance.yahoo.com
24th of September 2024
Is Applied Therapeutics Stock Outpacing Its Medical Peers This Year at zacks.com
23rd of September 2024
All You Need to Know About Applied Therapeutics Rating Upgrade to Buy at zacks.com
19th of September 2024
APLT Stock Soars 69 percent on Positive Update on Galactosemia Drug NDA at finance.yahoo.com
18th of September 2024
Applied Therapeutics Shares Gap Up to 4.65 at thelincolnianonline.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Applied Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Applied Therapeutics' short interest history, or implied volatility extrapolated from Applied Therapeutics options trading.
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.